Extended-release naltrexone to prevent opioid relapse in criminal justice offenders

JD Lee, PD Friedmann, TW Kinlock… - New England journal …, 2016 - Mass Medical Soc
… monthly injections of extended-release naltrexone (Vivitrol, … prevention of opioid relapse
among criminal justice offenders. … an opioid-relapse event would be lower, the time to relapse

Extended-release naltrexone opioid treatment at jail reentry (XOR)

…, J Rotrosen, MN Gourevitch, JD Lee - Contemporary Clinical …, 2016 - Elsevier
Extended-release naltrexone (XR-NTX), a long-acting, monthly injectable … the prevention
of opioid relapse following detoxification. XR-NTX's applications within the US criminal justice

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X: BOT): a multicentre, open-label …

JD Lee, EV Nunes, P Novo, K Bachrach, GL Bailey… - The Lancet, 2018 - thelancet.com
2016 US evaluation of XR-NTX versus treatment as usual among adults with opioid use
disorders and criminal justice … be effective at preventing opioid relapse; relapse was reduced by …

Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail

…, B Tofighi, AR Garment, J Giftos, JD Lee - Addiction science & …, 2019 - Springer
… Few studies have documented patient attitudes and experiences with extended-release
naltrexone (XR-NTX) opioid relapse prevention in criminal justice settings. This study assessed …

[PDF][PDF] The effectiveness of naltrexone for opioid use disorder among inmates: a systematic review and meta-analysis

A Bahji - J Adv Justice, 2019 - ntcrc.org
… are under criminal justice supervision, and warrants further … at arrests associated with the
Lee 2016 study included in this … assigned to extendedrelease naltrexone than among those …

Incidence of future arrests in adults involved in the criminal justice system with opioid use disorder receiving extended release naltrexone compared to treatment as …

WE Soares III, D Wilson, MS Gordon, JD Lee… - Drug and alcohol …, 2019 - Elsevier
opioid relapse, concerns regarding diversion and stigma limit treatment in CJS populations.
Extended release naltrexone (XR-NTX), as an opioidcriminal recidivism remains unknown. …

Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS)

…, A Suchocki, R Torralva, JP Wisdom, JD Lee - Journal of Substance …, 2021 - Elsevier
… of extended-release buprenorphine (XR-B) vs. extended-release naltrexone (XR-NTX) to
treat opioid use disorder (OUD) among criminal justice system (CJS)-involved adults in six US …

Extended-release naltrexone for opioid use disorder started during or following incarceration

T Lincoln, BD Johnson, P McCarthy… - Journal of Substance …, 2018 - Elsevier
… an opioid addiction treatment pilot program designed to promote addiction recovery
through implementation of extended-release naltrexone … In a larger criminal justice XR-NTX-treated …

Initiation of extended release naltrexone (XR-NTX) for opioid use disorder prior to release from prison

PD Friedmann, D Wilson, R Hoskinson Jr… - Journal of Substance …, 2018 - Elsevier
… with extended-release naltrexone (XR-NTX) shortly before release might reduce opioid
overdose … These findings are consistent with other work from community-based criminal justice

Acceptability and efficacy of naltrexone for criminal justice‐involved individuals with opioid use disorder: A systematic review and meta‐analysis

A Bahji, D Carlone, J Altomare - Addiction, 2020 - Wiley Online Library
… The opioid receptor antagonist naltrexone (NTX) is effective for the prevention of relapse
to OUD and may be more acceptable in criminal justice settings. The objectives of this review …